Sarah Rodriguez to Retinopathy of Prematurity
This is a "connection" page, showing publications Sarah Rodriguez has written about Retinopathy of Prematurity.
Connection Strength
9.817
-
Exposure to unblended oxygen may require earlier first retinopathy of prematurity screening examination and modification of existing screening guidelines in Sub-Saharan Africa. J AAPOS. 2024 Dec; 28(6):104053.
Score: 0.848
-
Risk factors for severe retinopathy of prematurity stratified by birth weight and gestational age in privately insured infants. J AAPOS. 2024 Dec; 28(6):104049.
Score: 0.847
-
Bevacizumab for Retinopathy of Prematurity Is Not Associated With Systemic Hypertension. J Pediatr Ophthalmol Strabismus. 2024 Nov-Dec; 61(6):434-441.
Score: 0.833
-
The impact of a multidisciplinary intervention to reduce severe retinopathy of prematurity in Kampala, Uganda. J Perinatol. 2025 Feb; 45(2):208-212.
Score: 0.830
-
Association of Health Insurance Status With Severity and Treatment Among Infants With Retinopathy of Prematurity. J Pediatr Ophthalmol Strabismus. 2023 Nov-Dec; 60(6):e75-e78.
Score: 0.789
-
Gut Microbiome and Retinopathy of Prematurity. Am J Pathol. 2023 11; 193(11):1683-1690.
Score: 0.750
-
Smartphone application links severity of retinopathy of prematurity to early motor behavior in a cohort of high-risk preterm infants. J AAPOS. 2023 02; 27(1):12.e1-12.e7.
Score: 0.746
-
Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis. J Perinatol. 2021 09; 41(9):2377-2378.
Score: 0.671
-
Two-Year Outcomes Comparing Anti-VEGF Injections to Laser for ROP Using a Commercial Claims Database. Ophthalmic Surg Lasers Imaging Retina. 2020 09 01; 51(9):486-493.
Score: 0.633
-
Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity. J AAPOS. 2020 06; 24(3):149.e1-149.e5.
Score: 0.621
-
Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):337-343.
Score: 0.580
-
Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS. 2019 04; 23(2):88.e1-88.e6.
Score: 0.570
-
Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226). Ophthalmology. 2018 10; 125(10):e70-e71.
Score: 0.277
-
Use of an Artificial Intelligence-Generated Vascular Severity Score Improved Plus Disease Diagnosis in Retinopathy of Prematurity. Ophthalmology. 2024 Nov; 131(11):1290-1296.
Score: 0.206
-
Macular Sequelae Following Exudative Retinal Detachment After Laser Photocoagulation for Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2020 Dec 01; 51(12):698-705.
Score: 0.161
-
A Potential Solution to Plus Disease Variability. Ophthalmol Retina. 2020 10; 4(10):1022-1023.
Score: 0.159
-
The early gut microbiome could protect against severe retinopathy of prematurity. J AAPOS. 2020 08; 24(4):236-238.
Score: 0.157
-
Bilateral Vitreous Hemorrhage Following Bilateral Intravitreal Injections of Bevacizumab in an Infant With Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2018 11 01; 49(11):893-896.
Score: 0.139